tiprankstipranks
Rezolute reports Q1 EPS (22c), consensus (33c)
PremiumThe FlyRezolute reports Q1 EPS (22c), consensus (33c)
1M ago
RZLT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
RZLT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
Rezolute initiated with an Outperform at Wedbush
Premium
The Fly
Rezolute initiated with an Outperform at Wedbush
2M ago
Rezolute clinical hold removal ‘best case scenario,’ says H.C. Wainwright
PremiumThe FlyRezolute clinical hold removal ‘best case scenario,’ says H.C. Wainwright
3M ago
‘Major overhang lifted’ on Rezolute, says Craig-Hallum
Premium
The Fly
‘Major overhang lifted’ on Rezolute, says Craig-Hallum
3M ago
Rezolute’s RZ358 Advances with FDA Clearance for Study
Premium
Company Announcements
Rezolute’s RZ358 Advances with FDA Clearance for Study
3M ago
Rezolute files to sell 4.5M shares of common stock for holders
PremiumThe FlyRezolute files to sell 4.5M shares of common stock for holders
5M ago
Rezolute Receives FDA Nod for Hypoglycemia Drug RZ358
Premium
Company Announcements
Rezolute Receives FDA Nod for Hypoglycemia Drug RZ358
5M ago
Rezolute announces FDA clearance of IND application for Phase 3 study of RZ358
Premium
The Fly
Rezolute announces FDA clearance of IND application for Phase 3 study of RZ358
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100